Market News AIOpen the app

STOK stock news · Stoke Therapeutics

Stories about Stoke Therapeutics (STOK) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for STOK

Follow Stoke Therapeutics (STOK) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for STOK
Free on the App Store and Google Play, or on the web.
  1. Oct 29, 2026, 7:55 PM ET · Results

    Stoke Therapeutics shared details from their earnings call for the third quarter of 2026.

    Good for STOK

    Stoke Therapeutics advanced its Dravet study, and the FDA supported part of its review plan. Cash is expected through early 2028, supporting a positive reading despite a quarterly loss.

  2. Sep 25, 2026, 4:15 PM ET · Market

    Stoke Therapeutics says Dr. Edward M. Kaye left its Board, and Bo Cumbo is the new director.

    Neutral

    Stoke replaced a departing board member with an independent director. The filing reports no disagreement or business change, so this board update does not change Stoke's outlook.